Diagnostic biomarkers for Parkinson's disease: focus on a-synuclein in cerebrospinal fluid

被引：18

作者：

Kalia, Lorraine V. ^{[1
,2
,3
,4
,5
]}

机构：

[1] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada

[2] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada

[3] Univ Hlth Network, Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Clin, Toronto, ON, Canada

[4] Univ Hlth Network, Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Div Neurol,Dept Med, Toronto, ON, Canada

[5] Univ Hlth Network, Toronto Western Hosp, Krembil Res Inst, Toronto, ON, Canada

来源：

PARKINSONISM & RELATED DISORDERS | 2019年 / 59卷

基金：

加拿大自然科学与工程研究理事会; 加拿大健康研究院;

关键词：

alpha-Synuclein; Aggregation; Biomarker; Cerebrospinal fluid; Oligomers; Parkinson's disease; Prion; Protein misfolding cyclic amplification assay; Real-time quaking -induced conversion; Seeding; ALPHA-SYNUCLEIN; STATISTICS NOTES; CSF; PROTEIN; UTILITY; TESTS;

D O I：

10.1016/j.parkreldis.2018.11.016

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Diagnostic biomarkers are measures that detect or confirm the presence of a disease or identify individuals with a subtype of the disease. For Parkinson's disease, unlike other neurodegenerative diseases such as Alzheimer's disease and Creutzfeldt-Jakob disease, diagnostic biomarkers remain elusive as none are yet available or approved for clinical use. A biomarker to diagnose early or prodromal Parkinson's disease with high accuracy would significantly enhance clinical practice as well as advance clinical therapeutic trials. Multiple lines of evidence support a role of a-synuclein in the pathophysiology of Parkinson's disease and hence major ongoing efforts to identify biomarkers for Parkinson's disease are aimed at measuring alpha-synuclein in peripheral tissues and biofluids, including cerebrospinal fluid. This work is still in the early stages of biomarker development and has been accompanied by both losses and victories. Here, alpha-synuclein in cerebrospinal fluid as a diagnostic marker for Parkinson's disease is reviewed, including measures of total alpha-synuclein, oligomeric and phosphorylated alpha-synuclein, and seeding activity of alpha-synuclein.

引用

页码：21 / 25

页数：5

共 45 条

[1] STATISTICS NOTES - DIAGNOSTIC-TESTS-1 - SENSITIVITY AND SPECIFICITY .3. [J].

ALTMAN, DG ;

BLAND, JM .

BRITISH MEDICAL JOURNAL, 1994, 308 (6943) :1552-1552

[2] Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein [J].

Atarashi, Ryuichiro ;

Moore, Roger A. ;

Sim, Valerie L. ;

Hughson, Andrew G. ;

Dorward, David W. ;

Onwubiko, Henry A. ;

Priola, Suzette A. ;

Caughey, Byron .

NATURE METHODS, 2007, 4 (08) :645-650

[3] Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion [J].

Atarashi, Ryuichiro ;

Satoh, Katsuya ;

Sano, Kazunori ;

Fuse, Takayuki ;

Yamaguchi, Naohiro ;

Ishibashi, Daisuke ;

Matsubara, Takehiro ;

Nakagaki, Takehiro ;

Yamanaka, Hitoki ;

Shirabe, Susumu ;

Yamada, Masahito ;

Mizusawa, Hidehiro ;

Kitamoto, Tetsuyuki ;

Klug, Genevieve ;

McGlade, Amelia ;

Collins, Steven J. ;

Nishida, Noriyuki .

NATURE MEDICINE, 2011, 17 (02) :175-178

[4] Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].

Atkinson, AJ ;

Colburn, WA ;

DeGruttola, VG ;

DeMets, DL ;

Downing, GJ ;

Hoth, DF ;

Oates, JA ;

Peck, CC ;

Schooley, RT ;

Spilker, BA ;

Woodcock, J ;

Zeger, SL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95

[5] Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4) [J].

Beach, Thomas G. ;

Serrano, Geidy E. ;

Kremer, Thomas ;

Canamero, Marta ;

Dziadek, Sebastian ;

Sade, Hadassah ;

Derkinderen, Pascal ;

Corbille, Anne-Gaelle ;

Letoumel, Franck ;

Munoz, David G. ;

White, Charles L., III ;

Schneider, Julie ;

Crary, John F. ;

Sue, Lucia I. ;

Adler, Charles H. ;

Glass, Michael J. ;

Intorcia, Anthony J. ;

Walker, Jessica E. ;

Foroud, Tatiana ;

Coffey, Christopher S. ;

Ecklund, Dixie ;

Riss, Holly ;

Gossmann, Jennifer ;

Koenig, Fatima ;

Kopil, Catherine M. ;

Arnedo, Vanessa ;

Riley, Lindsey ;

Linder, Carly ;

Dave, Kuldip D. ;

Jennings, Danna ;

Seibyl, John ;

Mollenhauer, Brit ;

Chahine, Lana .

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2018, 77 (09) :793-802

[6] Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders [J].

Beach, Thomas G. ;

Adler, Charles H. ;

Sue, Lucia I. ;

Vedders, Linda ;

Lue, LihFen ;

White, Charles L., III ;

Akiyama, Haru ;

Caviness, John N. ;

Shill, Holly A. ;

Sabbagh, Marwan N. ;

Walker, Douglas G. .

ACTA NEUROPATHOLOGICA, 2010, 119 (06) :689-702

[7] Unbiased Approaches to Biomarker Discovery in Neurodegenerative Diseases [J].

Chen-Plotkin, Alice S. .

NEURON, 2014, 84 (03) :594-607

[8] Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease [J].

Compta, Yaroslau ;

Valente, Tony ;

Saura, Josep ;

Segura, Barbara ;

Iranzo, Alex ;

Serradell, Monica ;

Junque, Carme ;

Tolosa, Eduard ;

Valldeoriola, Francesc ;

Munoz, Esteban ;

Santamaria, Joan ;

Camara, Ana ;

Fernandez, Manel ;

Fortea, Juan ;

Buongiorno, Mariateresa ;

Luis Molinuevo, Jose ;

Bargallo, Nuria ;

Jose Marti, Maria .

JOURNAL OF NEUROLOGY, 2015, 262 (02) :294-306

[9]

Cox T.M., 2006, FABRY DIS PERSPECTIV

[10] Statistics notes - Diagnostic tests 4: likelihood ratios [J].

Deeks, JJ ;

Altman, DG .

BRITISH MEDICAL JOURNAL, 2004, 329 (7458) :168-169

← 1 2 3 4 5 →